Rucker Michael A.'s Form 4 filing
Pediatrix Medical Group, Inc. (MD) · filed Nov 19, 2025
- Accession no.
- 0001193125-25-288277
- Filed
- Nov 19, 2025
- Trade date
- Nov 17, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $241.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rucker Michael A.CIK 0001588247 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Common Stock | SSaleDisposed | −10,478 | $23.00F1 | −$240,994 | 59,101 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $23.00 to $23.02 for a weighted average sales price of $23.00. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
See Exhibit 24.1 - Power of Attorney